Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV, Prospective, Single-Arm, Open-Label Study to Measure Outcomes in Patients With Pulmonary Arterial Hypertension Not on Active Treatment

NCT02191137 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT02191137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02191137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV, Prospective, Single-Arm, Open-Label Study to Measure Outcomes in Patients With Pulmonary Arterial Hypertension Not on Active Treatment
Lead sponsor
Bayer
Phase
Phase 4
Overall status
Completed
Start date
September 23, 2014
Completion date
July 16, 2016
Enrollment
75 (actual)
Sites
59

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, pulmonary